- Home
- LNTH vs PEGA Comparison
LNTH vs PEGA Comparison
Compare LNTH & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- PEGA
- Stock Information
- Founded
- LNTH 1956
- PEGA 1983
- Country
- LNTH United States
- PEGA United States
- Employees
- LNTH 808
- PEGA N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PEGA EDP Services
- Sector
- LNTH Health Care
- PEGA Technology
- Exchange
- LNTH Nasdaq
- PEGA Nasdaq
- Market Cap
- LNTH 3.8B
- PEGA 10.2B
- IPO Year
- LNTH 2015
- PEGA 1996
- Fundamental
- Price
- LNTH $56.28
- PEGA $67.62
- Analyst Decision
- LNTH Buy
- PEGA Buy
- Analyst Count
- LNTH 6
- PEGA 12
- Target Price
- LNTH $74.50
- PEGA $66.08
- AVG Volume (30 Days)
- LNTH 1.5M
- PEGA 1.5M
- Earning Date
- LNTH 11-06-2025
- PEGA 10-21-2025
- Dividend Yield
- LNTH N/A
- PEGA 0.18%
- EPS Growth
- LNTH N/A
- PEGA 116.89
- EPS
- LNTH 3.77
- PEGA 1.46
- Revenue
- LNTH $1,520,653,000.00
- PEGA $1,732,325,000.00
- Revenue This Year
- LNTH N/A
- PEGA $16.35
- Revenue Next Year
- LNTH $2.25
- PEGA $6.37
- P/E Ratio
- LNTH $14.86
- PEGA $45.31
- Revenue Growth
- LNTH 5.75
- PEGA 17.00
- 52 Week Low
- LNTH $47.25
- PEGA $29.84
- 52 Week High
- LNTH $118.21
- PEGA $67.19
- Technical
- Relative Strength Index (RSI)
- LNTH 55.37
- PEGA 74.03
- Support Level
- LNTH $56.03
- PEGA $60.96
- Resistance Level
- LNTH $57.94
- PEGA $67.00
- Average True Range (ATR)
- LNTH 1.56
- PEGA 2.39
- MACD
- LNTH 0.39
- PEGA 1.46
- Stochastic Oscillator
- LNTH 79.58
- PEGA 96.73
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.